Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PMOS to Evaluate the Compliance to Synagis (Palivizumab) Under Daily Pediatrician´s Conditions in Premature Infants 33 - 35 wGA Over 3 Consecutive Respiratory Syncytial Virus (RSV) Seasons in Austria

NCT01077271 is registered in ClinicalTrials.gov with Abbott as lead sponsor.

NCT NCT01077271
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01077271 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PMOS to Evaluate the Compliance to Synagis (Palivizumab) Under Daily Pediatrician´s Conditions in Premature Infants 33 - 35 wGA Over 3 Consecutive Respiratory Syncytial Virus (RSV) Seasons in Austria
Lead sponsor
Abbott
Phase
Observational
Overall status
Completed
Start date
October 31, 2008
Completion date
May 31, 2011
Enrollment
124 (actual)
Sites
45

Conditions

As the registry lists them; a condition with its own page is linked.

premature infants